Véronique Leblond, Melih Aktan, Christelle M. Ferra Coll, Caroline Dartigeas, Jens Kisro, Marco Montillo, João Raposo, Jean-Louis Merot, Susan Robson, Ekaterina Gresko, Francesc Bosch, Stephan Stilgenbauer, and Robin Foà. 2018. “Safety of Obinutuzumab Alone or Combined With Chemotherapy for Previously Untreated or relapsed/Refractory Chronic Lymphocytic Leukemia in the Phase IIIb GREEN Study”. Haematologica 103 (11). Pavia, Italy, 1889-98. https://doi.org/10.3324/haematol.2017.186387.